Today's Morning Top Gainers (SPEX,KERX,ACAS,AEZS,DARA)

Spherix Incorporated (NASDAQ: SPEX) is among the top percentage gainers in morning trade and surged 48% to $2.20 on huge volume of 405K million shares on no news. The stock has YTD of 1000%.

Keryx Biopharmaceuticals (NASDAQ: KERX) rallied 45.37% on 20.65 million shares and now trades at $2.26 followed its announcement that the company has received Orphan-Drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma. In August, the Company announced that it had reached an agreement with the FDA regarding a Special Protocol Assessment (SPA) on the design of a Phase 3 trial in relapsed/refractory multiple myeloma and that the study is expected to start by year-end.

American Capital Ltd. (NASDAQ: ACAS) is also moving higher by 27% to $3.26 after orning Incorporated announced today that it has acquired all the shares of Axygen BioScience, Inc. and its subsidiaries from American Capital Ltd. for approximately $400 million in cash.

AEterna Zentaris Inc. (USA) (NASDAQ: AEZS) soared 30.48 % now trades at $1.38 on an unusual volume of 4.85 million shares after today it announced that Keryx Biopharmaceuticals, Inc. its partner and licensee for perifosine in the North American market, has received orphan-drug designation for this compound from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.

DARA BioSciences, Inc. (NASDAQ: DARA) jumped up 45% to $0.702 on massive volume of 14.75 million shares on no news. In the last few trading sessions the stock has surged over 72%.